# Imipenem-Cilastatin Sodium

## Imipenem/Cilastatin Kabi 500/500mg Inj

| 藥物代碼 | ITIEN |
| :--- | :--- |
| 適應症 | Intra-abdominal, lower respiratory tract, gynecological, GUT, bone & joint, skin & soft tissue & mixed infections, endocarditis, septicemia. Prophylaxis of post-op infections. |
| 副作用 | Thrombophlebitis, pain, induration, erythema & tenderness following inj. Rash, urticaria, pruritus, GI disturbances, pseudomembranous colitis, haematological disturbances, increase in liver enzymes, taste perversion. Myoclonic activity, seizures, psychic disturbances, confusional states.Dermatologic: Injection site painGastrointestinal: Diarrhea \(1.8% \), Nausea \(2% \), Vomiting \(1.5% \)Hematologic: Thrombophlebitis \(3.1% \) |
| 禁忌 | Hypersensitivity to amide-type local anaesth, severe shock or heart block. |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest low risk |
| 附帶說明 | No reports describing the use of this antibiotic-enzyme inhibitor combination in the 1st trimester of nonterminated human pregnancies have been located. Four sources consider imipenem–cilastatin to be a safe and effective agent during the perinatal period |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | Small amounts of imipenem–cilastatin are excreted into breast milk. These amounts are comparable to other β-lactam antibiotics. The effects, if any, on a nursing infant are unknown. |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/S, D5W |
| 輸注點滴液 | 【D5W】 可選 仿單建議  【N/S】 可選 仿單建議 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 劑量≦500 mg時，滴注時間約20 ~ 30分鐘，當劑量大於 500 mg 時，滴注時間約40 ~ 60分鐘。 輸注溶液建議濃度：5 mg/mL of imipenam。 |
| 注意事項 | 1. 若病患有噁心感時應減慢滴注速率。 2. 監測體溫、CBC、肝腎功能，注意是否有肌肉震顫或癲癇發作徵狀。 3. 溶解或稀釋後之溶液須立即使用，由溶解開始至完成輸注時間間隔不得超逾 2 小時。 4. “卡比”疫必寧與乳酸鹽\(lactate\)屬化學配伍禁忌，所以不應以含乳酸鹽之溶液來稀釋。 |

